[Therapy of reflux esophagitis].
Berges
W
W
Luisenhospital, Abteilung Innere Medizin, Aachen.
Wienbeck
M
M
D000897:Anti-Ulcer Agents / Q000627:therapeutic use; D020117:Cisapride; D003131:Combined Modality Therapy; D004942:Esophagitis, Peptic / Q000209:etiology / Q000628:therapy*; D005260:Female; D005745:Gastric Acidity Determination; D006635:Histamine H2 Antagonists / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D009853:Omeprazole / Q000627:therapeutic use; D010880:Piperidines / Q000627:therapeutic use
D000897:Anti-Ulcer Agents; D006635:Histamine H2 Antagonists; D010880:Piperidines; D009853:Omeprazole; D020117:Cisapride
Therapie der Refluxösophagitis.